ABCC2 and colorectal cancer: This created an incomplete match in the data presented here between the clinical-gene expression dataset of colorectal cancer patients (Fig. 1) and our experimental work that mainly focussed on the HepG237 and PANC-1 lines that displayed MRP2-mediated transport-resistance to oxaliplatin in vitro (Fig. 3).